First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study

Mostafa M. Elserafi; Ahmed A. Zeeneldin; Ibrahim M. Abdelsalam; Hanan R. Nassar; Manar M. Moneer; Wafa H. Buhoush

doi:10.1016/j.jnci.2018.01.002

Citations

383

Views

Abstract not available for this publication.

Cite this Article (APA)

Mostafa, M. E., Ahmed, A. Z., Ibrahim, M. A., Hanan, R. N., Manar, M. M., Wafa, H. B. (2018). First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study. Journal of the Egyptian National Cancer Institute. https://doi.org/10.1016/j.jnci.2018.01.002